Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/31/2026

Adderall Dosing Guidelines for Children

Starting Dose Recommendations

  • The American Academy of Child and Adolescent Psychiatry recommends a therapeutic daily dose range of 2.5 mg – 40 mg for children, with an initial dose of 2.5 mg for ages 3‑5 years and 5 mg for ages 6 years and older【1】【2】.
  • For children 6 years and older, begin with 5 mg once or twice daily and increase by 5 mg each week until an optimal response is achieved【1】【2】.

Maximum Dose and Weight‑Based Limits

  • The FDA‑approved maximum total daily dose of amphetamine‑type stimulants is 40 mg【1】【2】.
  • For children weighing less than 25 kg, single‑dose amounts should not exceed 10 mg【1】【2】【3】.
  • Expert consensus commonly caps the upper daily limit at 40 mg of amphetamine【1】【2】【3】.

Titration Schedule and Monitoring

  • Dose increments of 2.5 – 5 mg per administration are advised when symptom control is insufficient【1】【2】【3】.
  • Weekly contact (phone or visit) is recommended throughout the titration phase, which typically lasts 2‑4 weeks【4】【3】.
  • Parent and teacher rating scales (e.g., ADHD Rating Scale, Conners scales) should be used to guide dose adjustments【1】【2】【3】.

Alternative “Forced” Titration Method

  • A forced titration trial may be employed, administering 2.5 mg, 5 mg, 7.5 mg, and 10 mg each for one week, then selecting the dose that provides the best benefit with the fewest side effects【5】【6】【7】.

Core Dosing Principles

  • If the highest recommended dose does not achieve adequate control, clinicians should consider switching medication or adding psychosocial interventions rather than exceeding the maximum dose【1】【2】【3】.

Common Pitfalls to Avoid

  • Weight‑adjusted dosing is not recommended as a routine practice because therapeutic response is unpredictable and not reliably correlated with body weight【8】【9】.
  • In younger children, titration should be performed cautiously; dose increases should be halted or reversed if adverse effects emerge【8】【9】.

Baseline and Ongoing Monitoring Requirements

  • Prior to initiating therapy, obtain baseline measurements of blood pressure, pulse, height, and weight【1】【2】【4】.
  • During titration, conduct weekly assessments of vital signs, side‑effects (e.g., insomnia, anorexia, headaches, tics, weight loss), and symptom response【1】【2】【3】.
  • In the maintenance phase, schedule monthly visits until symptoms are stable, then adjust visit frequency based on clinical response and side‑effect profile【4】【3】.

Expected Treatment Response

  • Approximately 70 % of children respond to either amphetamine or methylphenidate monotherapy, and nearly 90 % respond when both stimulant classes are trialed【5】【10】.
  • Stimulant effects appear rapidly; titration can often be completed within 7 days (as few as 3 days in urgent situations)【11】.

REFERENCES